Antibodies (Basel, Switzerland)
Lackner KJ, Müller-Calleja N.
PMID: 31557996
Antibodies (Basel). 2016 Jun 02;5(2). doi: 10.3390/antib5020015.
Antiphospholipid antibodies (aPL) are a hallmark of the antiphospholipid syndrome (APS), which is the most commonly acquired thrombophilia. To date there is consensus that aPL cause the clinical manifestations of this potentially devastating disorder. However, there is good evidence...
Cite
Lackner KJ, Müller-Calleja N. Antiphospholipid Antibodies: Their Origin and Development. Antibodies (Basel). 2016;5(2)doi: 10.3390/antib5020015.
Lackner, K. J., & Müller-Calleja, N. (2016). Antiphospholipid Antibodies: Their Origin and Development. Antibodies (Basel, Switzerland), 5(2), . https://doi.org/10.3390/antib5020015
Lackner, Karl J, and Müller-Calleja, Nadine. "Antiphospholipid Antibodies: Their Origin and Development." Antibodies (Basel, Switzerland) vol. 5,2 (2016). doi: https://doi.org/10.3390/antib5020015
Lackner KJ, Müller-Calleja N. Antiphospholipid Antibodies: Their Origin and Development. Antibodies (Basel). 2016 Jun 02;5(2). doi: 10.3390/antib5020015. PMID: 31557996; PMCID: PMC6698834.
Copy
Download .nbib
